TAIPEI, Taiwan & OSAKA, Japan–(Enterprise WIRE)–iXensor Co., Ltd. (6734. TWO)

iXensor, the pioneer of cellular health and fitness, now declared that Rohto Pharmaceutical Co., Ltd, a multinational pharmaceutical company headquartered in Japan, has turn out to be the new strategic spouse and shareholder. iXensor received Rohto Pharmaceutical’s strategic investment decision to extend its cell well being company globally and accelerate its PixoTech® platform licensing business.

Building on this strategic partnership, Rohto Pharmaceutical will deploy iXensor’s patented PixoTech® know-how to digitize its new products by way of a separate engineering licensing and joint enhancement settlement, thereby supplying Rohto Pharmaceutical’s shoppers with progressive self-screening portfolios including women’s wellness and infectious disorders in Japan market.

iXensor’s 1st merchandise, PixoTest® Glucose Monitoring Method, produced based mostly on its PixoTech® platform, is the world’s to start with US Fda-accredited smartphone digital camera-based mostly blood take a look at dated in 2017. The PixoTech®, now guarded by more than 70 worldwide patents, is iXensor’s core technological know-how system that transforms smartphones into in vitro diagnostic devices for biomedical analysis in place-of-care testing and self-testing. PixoTech® controls smartphones’ digicam sensing modules and display lighting emissions with various wavelengths to review all styles of immunoassay and enzymatic tests by way of the proprietary algorithm.

Mr. Hidetoshi Segi, Chief Method Officer of Rohto Pharmaceutical, commented, “By investing in iXensor, we can deepen our joint efforts on a sequence of new solution developments, hence growing our tests and diagnostic business enterprise as a result of a wave of electronic transformation. As the first step, we will get a technical license for smartphone-based diagnostic units and apps from iXensor to establish and promote progressive self-tests products and solutions.”

Dr. Carson Chen, CEO of iXensor, expressed, “This partnership represents the limitless opportunity and specialized gain of the PixoTech® system to renovate smartphones into precision clinical diagnostic units. The licensing small business of PixoTech® technological know-how started out shifting in as the new engine to travel iXensor’s expansion.”

In the article-pandemic period, iXensor endeavors to speed up the advancement of the at-home self-testing industry and empower the evolution of the digital health and fitness ecosystem via licensing the PixoTech® technological know-how. Many thanks to that, PixoTech® can be flexibly used to the digitalization of numerous lateral flow assessments. In addition, it can shorten the direct time for IVD makers venturing into the digital health business enterprise. It can also be applied to develop companion diagnostic or distant monitoring equipment for prescribed drugs to demonstrate the efficacy of new lessons of prescription drugs with precise check effects gathered from patients’ smartphones with consolation at residence.

About Rohto Pharmaceutical

Launched in 1899, Rohto Pharmaceutical is a renowned Japanese organization that has efficiently commercialized its analysis and progress of consumer and pharmaceutical goods globally. Rohto Pharmaceutical has recognized a sturdy product or service portfolio, including eye treatment, skincare, gastrointestinal medications, and purposeful foodstuff. Within the test drug enterprise, the novel coronavirus antigen immediate exam for medical institutions was introduced in response to the world epidemic in addition to the existing being pregnant exam, ovulation examination, and flu quick check items.

About iXensor

iXensor, the pioneer of cell wellness, turns smartphones into lab-quality cell healthcare diagnostics. In 2017, iXensor launched the PixoTest® Blood Glucose Checking Procedure as the world’s very first US Fda-authorized smartphone camera-primarily based blood examination. Dependent on the PixoTech® platform, iXensor has ventured into at-house self-testing and clinical issue-of-treatment diagnostics across infectious ailments, women’s wellness, diabetic issues, and cardiovascular diseases.

By Sia